Convexia (YC S25) — The world's first AI-maximalist pharma company
Before you sell to, join or invest in Convexia
MentionFox check on Convexia: only 1 source on file so far (checked 5 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/yc-convexia
Based on the record MentionFox holds for this company. No flag is not a clearance.
An AI-maximalist pharma platform. We use agents to buy drugs, run clinical trials, and sell for a profit.
Convexia is a Y Combinator company in the Summer 2025 batch. Its directory entry describes it as: The world's first AI-maximalist pharma company. The founders listed are Ayaan Parikh (Founder/CEO), Rahul Vijayan (Founder/CTO) (Y Combinator directory entry, July 12, 2025).
Get an email when Convexia changes status, grows its team or files a funding notice. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
An AI-maximalist pharma platform. We use agents to buy drugs, run clinical trials, and sell for a profit. 10x faster and 20x leaner than incumbents.
Sourcing Agent: Mines public/private databases and unstructured global data to surface overlooked preclinical candidates.
Scientific Agent: Runs comp bio models (ESM-3, RFdiffusion, Boltz-2, AlphaFold) to assess safety and efficacy in silico.
Commercial Agent: Analyzes FDA incentives, pricing dynamics, TAM, competitive landscape, and payer alignment.
Clinical Agent: Runs digital twin simulations, evaluates CRO/CMC risk, and builds trial plans to Phase 1.
PoS Agent: Evaluates the most critical factors that impact the likelihood of clinical trial success.
Built by 2 Stanford CS students who have built 3 startups together before.
Ayaan Parikh
Founder/CEO
Rahul Vijayan
Founder/CTO
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
One of 60 companies held here in Healthcare › Drug Discovery and Delivery.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Want the whole picture on Convexia?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Convexia: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Convexia covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
You get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Convexia: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
